Improving Drug Development and Decision-Making with AI

Explore transformative technologies and solutions in the life sciences industry. In this episode, join host Dr. Amar Drawid as he sits down with Dimitrios Skaltsas, CEO and co-founder of Intelligencia AI. Together, they delve into how Intelligencia AI harnesses AI-powered solutions to drive data-driven decision-making in clinical trials.

Discover how Intelligencia AI is revolutionizing the biopharmaceutical landscape by harmonizing clinical and biological data, accelerating and de-risking clinical development processes. Gain insights into their innovative approach, which enables faster and more accurate predictions around regulatory approvals, setting new standards in clinical trial efficiency and efficacy.

Tune in to explore how AI is reshaping the future of drug discovery and transforming the biopharmaceutical industry.

‍

Episode Highlights:

• Delving into how drug development can be enhanced using AI in decision-making.

• Discovering how Intelligencia AI addresses the formidable challenges in drug development.

• Understanding how Intelligencia AI reduces costs and shortens timelines from lab to patient.

• Exploring how biopharmaceutical companies make pipeline decisions about clinical trials and the potential for AI to enable faster and better decision-making on which programs to advance.

‍